Clinical trials are research studies that test new treatments for their safety and efficacy in volunteer participants. Clinical trials are vital for adding to medical knowledge that can improve patient care and outcomes. These research studies are necessary before a new treatment can be approved by the Food and Drug Administration for prescribing outside of clinical trials.
For many people with lung cancer, clinical trials have provided new treatment options when traditional treatments have been ineffective or when the benefits of those treatments are no long sustained.
Patients who participate in clinical trials will never be given less than the usual standard of care. They will usually receive either a new treatment or combination of treatments, or the current standard treatment.